Researchers at MIT have developed a light-sensitive molecule that can help a non-invasive form of optogenetics, a technology through which brain activity can be controlled by shining light on neurons that contain light-sensitive proteins which can suppress or stimulate electrical signals within cells. This noninvasive approach could pave the way to using optogenetics in human patients to treat epilepsy and other neurological disorders, the researchers say, although ...
via Medindia Health News
More READ
No comments:
Post a Comment